In addition, companies are working on potential diagnostic applications. The need for new medicines in these diseases provides ample financial incentive for the development of new peptide therapies.

PT-141, also known as bremelanotide, is a synthetic peptide that stimulates melanocortin receptors in the brain, specifically targeting the MC3R and MC4R subtypes. This mechanism of action is ...

a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo:4587) today announced its second wholly-owned peptide radiopharmaceutical ...

Lee also searched the internet for the top-rated peptide eye creams, perused reviews for dozens of popular options, and evaluated each on their features and customer reviews.

NEWARK, Del, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The global peptide supplements market has experienced impressive growth, with demand surging at a 9.2% CAGR until 2023. The market reached a ...